Melanoma Adjuvant Therapy: OS Data Gaps Explained

BREAKING: Melanoma Adjuvant Therapy Faces Reimbursement Concerns The lack of definitive overall survival data for adjuvant therapy in stage III melanoma is prompting worries about reimbursement and treatment… The post Melanoma Adjuvant Therapy: OS Data Gaps Explained appeared first on NewsyList. Source link

Many Early-Onset Cancers Increasing, Particularly in Women

Rates of certain cancers in the United States — including breast, colorectal, and thyroid cancers — increased between 2010 and 2019 among patients aged less than 50 years, while overall cancer incidence and mortality rates did not increase, a new study found.  Among the more than two million cases of early-onset cancer diagnosed during this … Read more

Blood Test Predicts Melanoma Recurrence

TOPLINE: Droplet digital polymerase chain reaction (PCR) measurements of circulating tumor DNA (ctDNA) identify patients with stage III melanoma who are at high risk for early recurrence during adjuvant targeted therapy. The blood-based biomarker outperforms traditional prognostic indicators including tumor mutational burden and interferon gamma gene expression. METHODOLOGY: Cell-free ctDNA is an established measure of … Read more

Expert Tips on Mohs Surgery for Melanoma

CORONADO, CALIF. — According to Christopher J. Arpey, MD, there is no single best approach to treating lentigo maligna (LM) and LM melanoma (LMM), but Mohs micrographic surgery is a sensible option in cases where margin size is critical and tissue conservation with precision is essential. At the annual Melanoma and Cutaneous Oncology Symposium, Arpey, … Read more

Cancer Care Post-Pandemic: What Has Changed and What’s Next – Medscape

Cancer Care Post-Pandemic: What Has Changed and What’s Next  Medscape Source link

How New Research Is Redefining Melanoma Treatment

The treatment landscape for melanoma saw significant advancements in 2024, as highlighted by Elisa Funck-Brentano, MD, PhD, from Ambroise-Paré Hospital in Paris, France, during her presentation at the 2024 Dermatology Days of Paris conference in Paris. Checkpoint Inhibitors in Neoadjuvant Therapy The standard approach for treating resectable stage III melanoma with locoregional metastases has traditionally … Read more

Integrative Approach to Sun Protection: Beyond Sunscreen

Protecting skin from photoaging and photocarcinogenesis requires not only sunscreen — ideally a mineral sunscreen with iron oxide — but also use of topical antioxidants, including polyphenols, and consideration of niacinamide and DNA repair enzymes, according to dermatologists who spoke at the annual Integrative Dermatology Symposium. “We used to talk about protection using UV [ultraviolet] filters, … Read more

Axolotl Shows Promise in Unlocking Skin Regeneration Secrets

For over 200 years, researchers have been captivated by axolotl salamanders (Ambystoma mexicanum) and their remarkable regenerative abilities, seeking to uncover secrets that could revolutionize regenerative medicine, including the scarless healing of wounds. “The axolotl salamander is the most studied animal ever in science for its neotenic ability to regenerate,” Jill S. Waibel, MD, dermatologist … Read more